黏蛋白与哮喘：我们正走向变革之路吗？
Mucins and Asthma: Are We Headed to the Revolutionary Road?
作者信息
Santus Pierachille, Radovanovic Dejan, Chiumello Davide Alberto
机构信息
Department of Biomedical and Clinical Sciences (DIBIC), Division of Respiratory Diseases, Università degli Studi di Milano, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco, Via G.B. Grassi, 74-20157 Milano, Italy.
SC Anestesia e Rianimazione, Ospedale San Paolo-Polo Universitario, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Via Antonio di Rudinì, 8-20142 Milano, Italy.
出版信息
J Clin Med. 2019 Nov 13;8(11):1955. doi: 10.3390/jcm8111955.
Abstract
Mucus represents the first line of defense of our respiratory tract and mucociliary clearance is essential for maintaining the homeostasis of airway epithelium. The latter mechanisms are altered in asthma and mucus plugging of proximal and distal airways is the main cause of death in cases of fatal asthma. Starting from the influential review performed by Luke R. Bonser and David J. Erle in 2017, we discuss the latest evidence in terms of mucins regulation and potential treatment of mucus hypersecretion and tissue remodeling in severe asthma.
摘要
黏液是我们呼吸道的第一道防线，黏液纤毛清除功能对于维持气道上皮的稳态至关重要。在哮喘中，后一种机制会发生改变，近端和远端气道的黏液阻塞是致死性哮喘病例死亡的主要原因。从卢克·R·邦泽和大卫·J·厄尔于2017年发表的有影响力的综述出发，我们讨论了黏蛋白调节以及重度哮喘中黏液高分泌和组织重塑的潜在治疗方面的最新证据。
相似文献
1
Mucins and Asthma: Are We Headed to the Revolutionary Road?黏蛋白与哮喘：我们正走向变革之路吗？
J Clin Med. 2019 Nov 13;8(11):1955. doi: 10.3390/jcm8111955.
2
Mucous hypersecretion and relationship to cough.黏液高分泌与咳嗽的关系。
Pulm Pharmacol Ther. 2013 Oct;26(5):510-3. doi: 10.1016/j.pupt.2013.02.003. Epub 2013 Feb 19.
3
Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma.富含MUC5AC的黏液的上皮栓系会损害哮喘中的黏液纤毛运输。
J Clin Invest. 2016 Jun 1;126(6):2367-71. doi: 10.1172/JCI84910. Epub 2016 May 16.
4
Airway Mucus and Asthma: The Role of MUC5AC and MUC5B.气道黏液与哮喘：MUC5AC和MUC5B的作用
J Clin Med. 2017 Nov 29;6(12):112. doi: 10.3390/jcm6120112.
5
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.致命性哮喘和轻度哮喘中呼吸道黏蛋白的表达
Histopathology. 2002 Apr;40(4):367-73. doi: 10.1046/j.1365-2559.2002.01378.x.
6
Mucins and Their Sugars. Critical Mediators of Hyperreactivity and Inflammation.黏蛋白及其糖类：高反应性和炎症的关键介质
Ann Am Thorac Soc. 2016 Mar;13 Suppl 1(Suppl 1):S98-9. doi: 10.1513/AnnalsATS.201511-743MG.
7
Mucins, Mucus, and Goblet Cells.黏蛋白、黏液和杯状细胞。
Chest. 2018 Jul;154(1):169-176. doi: 10.1016/j.chest.2017.11.008. Epub 2017 Nov 21.
8
Intracellular Processing of Human Secreted Polymeric Airway Mucins.人分泌型气道黏蛋白的细胞内加工。
Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S154-S158. doi: 10.1513/AnnalsATS.201802-143AW.
9
Th2-type cytokine-induced mucus metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection.Th2 型细胞因子诱导的黏液化生降低了人支气管上皮细胞对鼻病毒感染的易感性。
Am J Respir Cell Mol Biol. 2014 Aug;51(2):229-41. doi: 10.1165/rcmb.2013-0395OC.
10
Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.气道黏液的异质性：主要寡聚黏蛋白MUC5AC和MUC5B在数量和糖型上的变化
Biochem J. 2002 Feb 1;361(Pt 3):537-46. doi: 10.1042/0264-6021:3610537.
引用本文的文献
1
The epithelial era of asthma research: knowledge gaps and future direction for patient care.哮喘研究的上皮细胞时代：患者护理中的知识空白与未来方向。
Eur Respir Rev. 2024 Dec 18;33(174). doi: 10.1183/16000617.0221-2024. Print 2024 Oct.
2
Single-Cell Analysis: A Method for In-Depth Phenotyping of Cells Involved in Asthma.单细胞分析：一种用于哮喘相关细胞深度表型分析的方法。
Int J Mol Sci. 2024 Nov 25;25(23):12633. doi: 10.3390/ijms252312633.
3
Home Dust Mites Promote MUC5AC Hyper-Expression by Modulating the sNASP/TRAF6 Axis in the Airway Epithelium.室内尘螨通过调节气道上皮中的 sNASP/TRAF6 轴促进 MUC5AC 的过度表达。
Int J Mol Sci. 2022 Aug 20;23(16):9405. doi: 10.3390/ijms23169405.
4
CTNNAL1 participates in the regulation of mucus overproduction in HDM-induced asthma mouse model through the YAP-ROCK2 pathway.CTNNAL1通过YAP-ROCK2信号通路参与调控屋尘螨诱导的哮喘小鼠模型中的黏液过度分泌。
J Cell Mol Med. 2022 Mar;26(5):1656-1671. doi: 10.1111/jcmm.17206. Epub 2022 Jan 28.
5
Delivery Modality Affect Neonatal Levels of Inflammation, Stress, and Growth Factors.分娩方式影响新生儿的炎症、应激和生长因子水平。
Front Pediatr. 2021 Sep 22;9:709765. doi: 10.3389/fped.2021.709765. eCollection 2021.
6
Sesamol Alleviates Airway Hyperresponsiveness and Oxidative Stress in Asthmatic Mice.芝麻酚减轻哮喘小鼠的气道高反应性和氧化应激。
Antioxidants (Basel). 2020 Apr 1;9(4):295. doi: 10.3390/antiox9040295.
本文引用的文献
1
A phase 2 study to evaluate the safety, efficacy and pharmacokinetics of DP2 antagonist GB001 and to explore biomarkers of airway inflammation in mild-to-moderate asthma.一项评估 DP2 拮抗剂 GB001 的安全性、疗效和药代动力学，并探索轻度至中度哮喘气道炎症生物标志物的 2 期研究。
Clin Exp Allergy. 2020 Feb;50(2):189-197. doi: 10.1111/cea.13524. Epub 2019 Nov 26.
2
Efficient RNP-directed Human Gene Targeting Reveals SPDEF Is Required for IL-13-induced Mucostasis.高效 RNP 指导的人类基因靶向揭示 SPDEF 是 IL-13 诱导的黏液生成所必需的。
Am J Respir Cell Mol Biol. 2020 Mar;62(3):373-381. doi: 10.1165/rcmb.2019-0266OC.
3
Cucurbitacin E ameliorates lipopolysaccharide-evoked injury, inflammation and MUC5AC expression in bronchial epithelial cells by restraining the HMGB1-TLR4-NF-κB signaling.葫芦素 E 通过抑制 HMGB1-TLR4-NF-κB 信号通路减轻脂多糖诱导的支气管上皮细胞损伤、炎症和 MUC5AC 表达。
Mol Immunol. 2019 Oct;114:571-577. doi: 10.1016/j.molimm.2019.09.008. Epub 2019 Sep 13.
4
The impact of the prostaglandin D receptor 2 and its downstream effects on the pathophysiology of asthma.前列腺素 D 受体 2 及其下游效应对哮喘病理生理学的影响。
Allergy. 2020 Apr;75(4):761-768. doi: 10.1111/all.14001. Epub 2019 Aug 20.
5
Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.当前和未来用于重度哮喘的靶向治疗：基于表型和生物标志物的生物制剂治疗管理。
Pharmacol Res. 2019 Aug;146:104296. doi: 10.1016/j.phrs.2019.104296. Epub 2019 Jun 4.
6
Natural inhibitors on airway mucin: Molecular insight into the therapeutic potential targeting MUC5AC expression and production.气道黏液糖蛋白的天然抑制剂：靶向 MUC5AC 表达和产生的治疗潜力的分子见解。
Life Sci. 2019 Aug 15;231:116485. doi: 10.1016/j.lfs.2019.05.041. Epub 2019 May 19.
7
CT and Functional MRI to Evaluate Airway Mucus in Severe Asthma.CT 和功能性磁共振成像评估严重哮喘的气道黏液。
Chest. 2019 Jun;155(6):1178-1189. doi: 10.1016/j.chest.2019.02.403. Epub 2019 Mar 23.
8
TAS-203, an oral phosphodiesterase 4 inhibitor, exerts anti-inflammatory activities in a rat airway inflammation model.TAS-203，一种口服磷酸二酯酶 4 抑制剂，在大鼠气道炎症模型中发挥抗炎活性。
Eur J Pharmacol. 2019 Apr 15;849:22-29. doi: 10.1016/j.ejphar.2019.01.068. Epub 2019 Feb 1.
9
Bronchial Thermoplasty for Severe Asthma with Mucus Hypersecretion.用于治疗伴有黏液高分泌的重度哮喘的支气管热成形术
Intern Med. 2019 Jun 1;58(11):1613-1616. doi: 10.2169/internalmedicine.1730-18. Epub 2019 Feb 1.
10
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study.欧洲裔人群中中重度哮喘的全基因组关联研究。
Lancet Respir Med. 2019 Jan;7(1):20-34. doi: 10.1016/S2213-2600(18)30389-8. Epub 2018 Dec 11.
Zotero 插件